| Literature DB >> 31847159 |
Katarína Kozics1, Mária Bučková2, Andrea Puškárová2, Viktória Kalászová3, Terézia Cabicarová4, Domenico Pangallo2.
Abstract
In this study, we determined the antimicrobial activity of ten essential oils (EOs)-oregano, thyme, clove, arborvitae, cassia, lemongrass, melaleuca, eucalyptus, lavender, and clary sage-against drug-resistant microorganisms previously isolated from patients with skin infections. The essential oil compositions were determined using gas chromatography coupled to mass spectrometry (GC/MS). The assayed bacteria included Pseudomonas aeruginosa, Proteus vulgaris, Citrobacter koseri, and Klebsiella pneumoniae. Two drug-resistant yeasts (Candida albicans and Candida parapsilosis) were also involved in our survey. Oregano, thyme, cassia, lemongrass and arborvitae showed very strong antibacterial and antifungal activity against all tested strains. These results show that these essential oils may be effective in preventing the growth of the drug-resistant microorganisms responsible for wound infections. In this study, the genotoxic effects of tested essential oils on healthy human keratinocytes HaCaT were evaluated using the comet assay for the first time. These results revealed that none of the essential oils induced significant DNA damage in vitro after 24 h. Moreover, the treatment of HaCaT cells with essential oils increased the total antioxidant status (TAS) level. The obtained results indicate that EOs could be used as a potential source of safe and potent natural antimicrobial and antioxidant agents in the pharmaceutical and food industries.Entities:
Keywords: cyto/genotoxic effects; drug-resistant Candida; essential oils; human keratinocytes HaCaT; multi-drug-resistant bacteria; total antioxidant status
Mesh:
Substances:
Year: 2019 PMID: 31847159 PMCID: PMC6943746 DOI: 10.3390/molecules24244570
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Gas chromatography–mass spectrometry analysis of ten essential oils.
|
|
| Carvacrol (76.73%), Thymol (11.34%), |
|
|
| Thymol (53.26%), Carvacrol (6.27%), |
|
|
| Eugenol (77.83%), Eugenyl acetate (14.22%), β-Caryophyllene (5.07%) |
|
|
| Methyl thujate (55.96%), Methyl myrtenate (6.21%), Terpinen-4-ol (2.97%), α-Terpineol (2.06%) |
|
|
| |
|
|
| Geranial (45.72%), Neral (34.46%), Geraniol (5.99%), Geranyl acetate (3.83%) |
|
|
| Terpinen-4-ol (44.48%), γ-Terpinene (16.84%), α-Terpinene (6.40%) |
|
|
| Eucalyptol (73.82%), α-Terpineol (9.88%) |
|
|
| Linalyl acetate (53.65%), Linalool (22.32%), α-Terpineol (5.93%), Geranyl acetate (4.32%), Neryl acetate (2.37%) |
|
|
| Linalyl acetate (29.15%), Linalool (30.07%), Terpinen-4-ol (4.66%), Lavandulyl acetate (5.56%), β-Caryophyllene (4.16%), cis-β-Ocimene (3.93%) |
Susceptibility to antibiotics of multi-drug-resistant bacteria.
| Bacteria | CEF | CTX | CAZ | CPM | SUB | AMP | AMS | TIG | TET | CLM | CIP | COL | GEN | TOB | AMI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R | R | S | R | R | S | R | S | R | R | R | S | R | R | R | |
| R | R | S | R | S | R | R | R | R | R | R | R | R | R | S | |
| R | R | R | R | S | R | R | S | S | R | R | S | R | R | S | |
| C. | R | R | S | R | S | R | R | R | R | R | R | R | R | R | S |
CEF: cefuroxime; CTX: cefotaxime; CAZ: ceftazidime; CPM cefepime; SUB: sulbactam; AMP: ampicillin; AMS: ampicillin + sulbactam; TIG: tigecykline; TET: tetracycline; CLM: clotrimazole; CIP: ciprofloxacin; COL: colistin; GEN: gentamicin; TOB: tobramycin; AMI: amikacin; R: resistant; S: susceptible.
Susceptibility to antimycotics of drug-resistant yeasts.
| FLU | VOR | |
|---|---|---|
| R | S | |
| S | R | |
| R | R |
FLU fluconazole; VOR voriconazole; R: resistant; S: susceptible.
Figure 1Antibacterial activity of assayed essential oils. Cefuroxime (30 μg/disc) was used as a positive control for bacterial inhibition. Each bar of the chart shows the mean diameter of the inhibition halos obtained for each essential oil (EO) analyzed; (1) P. aeruginosa KMB527, (2) P. vulgaris KMB525, (3) K. pneumoniae KMB522, (4) C. koseri KMB526. Data are represented by means ± 1 SD of three independent experiments. * p < 0.05; ** p < 0.01; *** p < 0.001 indicate statistically significant differences compared to the control (Student’s t-test).
Figure 2Antifungal activity of assayed essential oils. Fluconazole (20 μg/disc) was used as a positive control for fungal inhibition. Each bar of the chart shows the mean diameter of the inhibition halos obtained for each EO analyzed; (1) C. albicans Nr. 2, (2) C. parapsilosis Nr. 8, (3) C. parapsilosis Nr. 52. Data are represented by means ± 1 SD of three independent experiments. * p < 0.05; ** p < 0.01; *** p < 0.001 indicate statistically significant differences compared to the control (Student’s t-test).
Minimum inhibitory concentrations (MIC; % w/v), minimum bactericidal concentrations (MBC; % w/v), and minimum fungicidal concentrations (MFC; % w/v) of several EOs against tested microorganisms.
| Microorganisms | Activity | OR | TY | CL | AR | CA | LE | ME | EU | LA | SA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| MIC | 0.125 | 0.125 | 0.5 | 0.25 | 0.125 | 0.25 | 0.5 | 2.5 | - | - | |
| MBC | 0.125 | 0.125 | 0.5 | 0.25 | 0.125 | 0.25 | 0.5 | - | - | - | ||
| MIC | 0.05 | 0.05 | 0.125 | 0.125 | 0.025 | 0.25 | 0.125 | 1.25 | 0.5 | 0.5 | ||
| MBC | 0.05 | 0.05 | 0.125 | 0.125 | 0.025 | 0.25 | 0.125 | 1.25 | 0.5 | 0.5 | ||
| MIC | 0.05 | 0.05 | 0.125 | 0.125 | 0.125 | 0.25 | 0.125 | 1.25 | 0.5 | 0.5 | ||
| MBC | 0.05 | 0.05 | 0.125 | 0.125 | 0.125 | 0.25 | 0.125 | 1.25 | 0.5 | 0.5 | ||
| MIC | 0.025 | 0.025 | 0.125 | 0.05 | 0.05 | 0.25 | 0.025 | 1.25 | 0.5 | 0.5 | ||
| MBC | 0.025 | 0.025 | 0.125 | 0.05 | 0.05 | 0.25 | 0.025 | 1.25 | 0.5 | 0.5 | ||
|
| MIC | 0.05 | 0.05 | 0.5 | 0.05 | 0.125 | 0.125 | 0.125 | 2.5 | - | - | |
| MFC | 0.05 | 0.05 | 0.5 | 0.05 | 0.125 | 0.125 | 0.125 | - | - | - | ||
| MIC | 0.05 | 0.05 | 0.5 | 0.05 | 0.125 | 0.125 | 0.125 | 2.5 | - | - | ||
| MFC | 0.05 | 0.05 | 0.5 | 0.05 | 0.125 | 0.125 | 0.125 | - | - | - | ||
| MIC | 0.05 | 0.05 | 0.5 | 0.05 | 0.125 | 0.125 | 0.125 | 2.5 | - | - | ||
| MFC | 0.05 | 0.05 | 0.5 | 0.05 | 0.125 | 0.125 | 0.125 | - | - | - | ||
OR: oregano; TY: thyme; CL: clove; AR: arborvitae; CA: cassia; LE: lemongrass; ME: melaleuca; EU: eucalyptus; LA: lavender; SA: clary sage; -: no growth inhibition.
Figure 3Cytotoxicity/viability of HaCaT cells treated with essential oils (0.00–0.25% w/v) for 24 h. (CA: cassia; CL: clove; LA: lavender; ME: melaleuca; OR: oregano; LE: lemongrass; AR: arborvitae; TY: thyme; EU: eucalyptus; SA: clary sage).
The levels of DNA single strand breaks (% of tail DNA) in HaCaT cells after the exposure to essential oils for 24 h. Data represent means ± SD of three independent experiments.
| EOs | Concentrations of EOs | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 6.25 × 10−5 | 1.25 × 10−4 | 2.5 × 10−4 | 5 × 10−4 | 1 × 10−3 | 2 × 10−3 | 4 × 10−3 | 8 × 10−3 | 1.6 × 10−2 | 3.2 × 10−2 | 6.4 × 10−2 | |
|
| 7.62 ± 0.80 | 8.92 ± 0.10 | 9.21 ± 0.99 | 8.98 ± 0.90 | 8.68 ± 0.11 | 9.59 ± 0.26 | 7.88 ± 0.30 | 6.93 ± 0.90 | 7.71 ± 0.99 | ND | ND | ND |
|
| 8.65 ± 0.27 | 9.71 ± 1.09 | 8.91 ± 1.16 | 7.18 ± 0.75 | 8.03 ± 1.42 | 8.50 ± 1.31 | 7.09 ± 1.91 | 8.44 ± 0.63 | 7.61 ± 0.99 | ND | ND | ND |
|
| 7.61 ± 1.15 | 9.29 ± 0.88 | 7.71 ± 1.45 | 8.82 ± 0.86 | 9.73 ± 0.98 | 9.93 ± 1.54 | 7.64 ± 1.47 | 8.27 ± 0.49 | 8.69 ± 0.53 | ND | ND | ND |
|
| 9.86 ± 1.22 | 11.21 ± 1.46 | 9.95 ± 1.61 | 11.93 ± 1.16 | 10.28 ± 1.19 | 11.62 ± 1.46 | 10.74 ± 1.73 | 10.92 ± 1.15 | 9.63 ± 1.12 | ND | ND | ND |
|
| 8.34 ± 0.58 | 8.29 ± 0.88 | 7.82 ± 0.86 | 7.50 ± 1.31 | 7.55 ± 1.04 | 7.19 ± 0.96 | 8.17 ± 1.22 | 8.18 ± 0.96 | 7.49 ± 0.66 | 7.56 ± 0.37 | 7.20 ± 0.42 | 7.61 ± 0.79 |
|
| 8.29 ± 0.67 | 9.31 ± 1.92 | 9.11 ± 2.19 | 10.37 ± 0.89 | 9.07 ± 1.57 | 8.18 ± 1.22 | 10.06 ± 1.60 | 8.89 ± 0.66 | ND | ND | ND | ND |
|
| 10.12 ± 0.66 | 9.33 ± 1.06 | 10.04 ± 1.27 | 8.73 ± 0.79 | 7.89 ± 0.78 | 9.86 ± 1.34 | 10.57 ± 0.90 | 8.89 ± 0.52 | 10.58 ± 1.11 | ND | ND | ND |
|
| 9.24 ± 0.60 | 8.29 ± 1.36 | 8.61 ± 0.82 | 9.02 ± 1.32 | 7.69 ± 1.20 | 9.25 ± 1.00 | 8.27 ± 1.30 | 8.76 ± 0.81 | 9.53 ± 1.43 | ND | ND | ND |
|
| 8.27 ± 1.32 | 9.29 ± 0.66 | 9.28 ± 1.04 | 9.02 ± 0.33 | 9.02 ± 1.18 | 9.82 ± 0.29 | 8.60 ± 1.37 | 10.09 ± 0.60 | 9.53 ± 1.43 | ND | ND | ND |
|
| 8.24 ± 0.54 | 7.59 ± 1.20 | 9.32 ± 0.32 | 8.58 ± 1.25 | 8.93 ± 1.58 | 9.69 ± 1.19 | 8.42 ± 1.70 | 8.40 ± 1.04 | 8.04 ± 0.68 | ND | ND | ND |
ND: (not detectable); positive control - hydrogen peroxide (300 μmol/L), 50.94 ± 1.76.
Total antioxidant status (TAS) in HaCaT cells exposed to essential oils for 24 h.
| Essential Oil | Dose (% | TAS (mmol/prot) |
|---|---|---|
|
| - | 0.54 ± 0.04 |
|
| - | 4.32 ± 0.08 |
|
| 8 × 10−3 | 0.56 ± 0.07 |
| 4 × 10−3 | 0.71 ± 0.07 ** | |
| 2 × 10−3 | 0.73 ± 0.03 ** | |
|
| 8 × 10−3 | 0.74 ± 0.12** |
| 4 × 10−3 | 1.03 ± 0.08 ** | |
| 2 × 10−3 | 1.45 ± 0.06 ** | |
|
| 8 × 10−3 | 1.53 ± 0.08 ** |
| 4 × 10−3 | 2.07 ± 0.13 *** | |
| 2 × 10−3 | 2.20 ± 0.16 *** | |
|
| 6.4 × 10−2 | 0.78 ± 0.12 ** |
| 3.2 × 10−2 | 1.19 ± 0.06 *** | |
| 1.6 × 10−2 | 1.51 ± 0.28 ** | |
|
| 8 × 10−3 | 1.47 ± 0.11 ** |
| 4 × 10−3 | 2.01 ± 0.14 *** | |
| 2 × 10−3 | 2.72 ± 0.09 *** | |
|
| 4 × 10−3 | 0.42 ± 0.08 |
| 2 × 10−3 | 0.91 ± 0.13 ** | |
| 1 × 10−3 | 1.01 ± 0.08 ** | |
|
| 8 × 10−3 | 0.61 ± 0.05 * |
| 4 × 10−3 | 0.65 ± 0.09 * | |
| 2 × 10−3 | 0.89 ± 0.07 ** | |
|
| 8 × 10−3 | 0.77 ± 0.11 * |
| 4 × 10−3 | 1.13 ± 0.09 *** | |
| 2 × 10−3 | 1.47 ± 0.12 ** | |
|
| 8 × 10−3 | 0.75 ± 0.04 ** |
| 4 × 10−3 | 1.31 ± 0.11 ** | |
| 2 × 10−3 | 1.41 ± 0.10 ** | |
|
| 8 × 10−3 | 0.77 ± 0.08 ** |
| 4 × 10−3 | 0.93 ± 0.05 ** | |
| 2 × 10−3 | 1.23 ± 0.05 *** |
Data represent mean ± SD of three independent experiments. * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant differences compared to untreated control cells.